Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus

Tekijä Stewart, Hazel, Adema, Karen W, McMonagle, Elizabeth L, Hosie, Margaret J, Willett, Brian J
Julkaistu 2012

Highly Sensitive Methods Based on Seminested Real-Time Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 Unspliced and Multiply Spliced RNA and Prov...

Tekijä Pasternak, Alexander O., Adema, Karen W., Bakker, Margreet, Jurriaans, Suzanne, Berkhout, Ben, Cornelissen, Marion, Lukashov, Vladimir V.
Julkaistu 2008

Identification of a Feline Leukemia Virus Variant That Can Use THTR1, FLVCR1, and FLVCR2 for Infection

Tekijä Shalev, Zvi, Duffy, Simon P., Adema, Karen W., Prasad, Rati, Hussain, Naveen, Willett, Brian J., Tailor, Chetankumar S.
Julkaistu 2009

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised,...

Tekijä de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, Colombo, Alessandro, Fyles, Anthony, Baron, Marie-Helene, Jürgenliemk-Schulz, Ina M, Kitchener, Henry C, Nijman, Hans W, Wilson, Godfrey, Brooks, Susan, Carinelli, Silvestro, Provencher, Diane, Hanzen, Chantal, Lutgens, Ludy C H W, Smit, Vincent T H B M, Singh, Naveena, Do, Viet, D'Amico, Romerai, Nout, Remi A, Feeney, Amanda, Verhoeven-Adema, Karen W, Putter, Hein, Creutzberg, Carien L
Julkaisussa Lancet Oncol (2018)

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised ph...

Tekijä de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, D'Amico, Romerai, Fyles, Anthony, Baron, Marie-Helene, Jürgenliemk-Schulz, Ina M, Kitchener, Henry C, Nijman, Hans W, Wilson, Godfrey, Brooks, Susan, Gribaudo, Sergio, Provencher, Diane, Hanzen, Chantal, Kruitwagen, Roy F, Smit, Vincent T H B M, Singh, Naveena, Do, Viet, Lissoni, Andrea, Nout, Remi A, Feeney, Amanda, Verhoeven-Adema, Karen W, Putter, Hein, Creutzberg, Carien L
Julkaisussa Lancet Oncol (2019)

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

Tekijä van den Heerik, Anne Sophie V M, Horeweg, Nanda, Nout, Remi A, Lutgens, Ludy C H W, van der Steen-Banasik, Elzbieta M, Westerveld, G Henrike, van den Berg, Hetty A, Slot, Annerie, Koppe, Friederike L A, Kommoss, Stefan, Mens, Jan Willem M, Nowee, Marlies E, Bijmolt, Stefan, Cibula, David, Stam, Tanja C, Jurgenliemk-Schulz, Ina M, Snyers, An, Hamann, Moritz, Zwanenburg, Aleida G, Coen, Veronique L M A, Vandecasteele, Katrien, Gillham, Charles, Chargari, Cyrus, Verhoeven-Adema, Karen W, Putter, Hein, van den Hout, Wilbert B, Wortman, Bastiaan G, Nijman, Hans W, Bosse, Tjalling, Creutzberg, Carien L
Julkaisussa Int J Gynecol Cancer (2020)